pantoprazole has been researched along with Hypoproteinemia in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Hypoproteinemia: A condition in which total serum protein level is below the normal range. Hypoproteinemia can be caused by protein malabsorption in the gastrointestinal tract, EDEMA, or PROTEINURIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babinets', LS | 1 |
| Halabits'ka, IM | 1 |
| Botsiuk, NIe | 1 |
| Riabokon', SS | 1 |
1 other study available for pantoprazole and Hypoproteinemia
| Article | Year |
|---|---|
[Pathogenetic grounds of trophological impact of chronic pancreatitis complex therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amino Acids; Antioxidants; Ascorbic Acid; Cata | 2014 |